CCR5 deficiency increases risk of symptomatic West Nile virus infection

Journal of Experimental Medicine

Volumn 203, Issue 1, 2006, Pages 35-40

  Glass, William G ^a,e   McDermott, David H ^a   Lim, Jean K ^a   Lekhong, Sudkamon ^b   Shuk, Fong Yu ^b   Frank, William A ^c   Pape, John ^d   Cheshier, Ronald C ^b   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Arizona Department   (United States)

^c Bureau of Epidemiology and Disease Control   (United States)

^d Colorado Department of Public Health and Environment ^*  (United States)

^e CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HOMOZYGOTE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; ODDS RATIO; RECEPTORS, CCR5; WEST NILE FEVER; WEST NILE VIRUS;

EID: 31344465937     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051970     Document Type: Article

References (21)

1. Lanciotti, R.S., J.T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K.E. Volpe, M.B. Crabtree, J.H. Scherret, et al. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 286:2333-2337.
2. Hubalek, Z., and J. Halouzka. 1999. West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis. 5:643-650.
3. Hayes, E.B., and D.J. Gubler. 2005. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev. Med. DOI:10.1146/annurev.med.57.121304.131418.
4. Smithburn, K.C., T.P. Hughes, A.W. Burke, and J.H. Paul. 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20:471-492.
5. Klee, A.L., B. Maidin, B. Edwin, I. Poshni, F. Mostashari, A. Fine, M. Layton, and D. Nash. 2004. Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis. 10:1405-1411.
6. Asnis, D.S., R. Conetta, G. Waldman, and A.A. Teixeira. 2001. The West Nile virus encephalitis outbreak in the United States (1999-2000): from Flushing, New York, to beyond its borders. Ann. NY Acad. Sci. 951:161-171.
7. Centers for Disease Control and Prevention. 2004. West Nile virus activity - United States, October 6-12, 2004. MMWR Morb. Mortal. Wkly. Rep. 53:950-951.
8. Centers for Disease Control and Prevention. 2003. West Nile virus activity - United States, November 20-25, 2003. MMWR Morb. Mortal. Wkly. Rep. 52:1160.
9. Centers for Disease Control and Prevention. 2002. West Nile virus activity - United States, November 14-20, 2002, and Missouri, January 1-November 9, 2002. MMWR Morb. Mortal. Wkly. Rep. 51:1049-1051.
10. Tsai, T.F., F. Popovici, C. Cernescu, G.L. Campbell, and N.I. Nedelcu. 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet. 352:767-771.
11. Asnis, D.S., R. Conetta, A.A. Teixeira, G. Waldman, and B.A. Sampson. 2000. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin. Infect. Dis. 30:413-418.
12. Glass, W.G., J.K. Lim, R. Cholera, A.G. Pletnev, J.L. Gao, and P.M. Murphy. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202:1087-1098.
13. Shirato, K., T. Kimura, T. Mizutani, H. Kariwa, and I. Takashima. 2004. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 74:507-513.
14. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
15. Zimmerman, P.A., A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, et al. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3:23-36.
16. Berger, E.A., P.M. Murphy, and J.M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
17. Hill, A.V. 1998. The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16:593-617.
18. Martinson, J.J., N.H. Chapman, D.C. Rees, Y.T. Liu, and J.B. Clegg. 1997. Global distribution of the CCR5 gene 32-basepair deletion. Nat. Genet. 16:100-103.
19. Omalu, B.I., A.A. Shakir, G. Wang, W.I. Lipkin, and C.A. Wiley. 2003. Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol. 13:465-472.
20. Yang, J.S., J.J. Kim, D. Hwang, A.Y. Choo, K. Dang, H. Maguire, S. Kudchodkar, M.P. Ramanathan, and D.B. Weiner. 2001. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J. Infect. Dis. 184:809-816.
21. Abdi, R., T.B. Tran, A. Sahagun-Ruiz, P.M. Murphy, B.M. Brenner, E.L. Milford, and D.H. McDermott. 2002. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J. Am. Soc. Nephrol. 13:754-758.